Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of Engineered-U1 snRNA Therapies: Current Status. | Int J Mol Sci | 2023 | 37834063 | PubTator, text mining | PubMed |
| The Integration of Proteogenomics and Ribosome Profiling Circumvents Key Limitations to Increase the Coverage and Confidence of Novel Microproteins. | bioRxiv | 2023 | 37808637 | PubTator, text mining | PubMed |
| Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets. | Front Mol Biosci | 2023 | 37780208 | PubTator, text mining | PubMed |
| Progression of Rare Inherited Retinal Dystrophies May Be Monitored by Adaptive Optics Imaging. | Life (Basel) | 2023 | 37763275 | PubTator, text mining | PubMed |
| Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections. | Int J Mol Sci | 2023 | 37762059 | PubTator, text mining | PubMed |
| Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results. | Stem Cells Transl Med | 2023 | 37713598 | PubTator, text mining | PubMed |
| RPGR: Deep Phenotyping and Genetic Characterization With Findings Specific to the 3'-end of ORF15. | Invest Ophthalmol Vis Sci | 2023 | 37695603 | PubTator, text mining | PubMed |
| Revisiting Retinal Degeneration Hallmarks: Insights from Molecular Markers and Therapy Perspectives. | Int J Mol Sci | 2023 | 37685886 | PubTator, text mining | PubMed |
| Structural characterization of human RPA70N association with DNA damage response proteins. | Elife | 2023 | 37668474 | PubTator, text mining | PubMed |
| Investigating the associations of macular edema in retinitis pigmentosa. | Sci Rep | 2023 | 37648803 | PubTator, text mining | PubMed |
| Diagnostic implications of pitfalls in causal variant identification based on 4577 molecularly characterized families. | Nat Commun | 2023 | 37644014 | PubTator, text mining | PubMed |
| RP2 X-LINKED RETINITIS PIGMENTOSA CARRIER STATE PRESENTING WITH VASCULAR LEAKAGE AND UNILATERAL MACULAR ATROPHY. | Retin Cases Brief Rep | 2023 | 37643038 | PubTator, text mining | PubMed |
| A Splicing Variant in RDH8 Is Associated with Autosomal Recessive Stargardt Macular Dystrophy. | Genes (Basel) | 2023 | 37628710 | PubTator, text mining | PubMed |
| Fault Diagnosis for Rolling Bearing of Combine Harvester Based on Composite-Scale-Variable Dispersion Entropy and Self-Optimization Variational Mode Decomposition Algorithm. | Entropy (Basel) | 2023 | 37628141 | PubTator, text mining | PubMed |
| Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers. | J Clin Immunol | 2023 | 37620741 | PubTator, text mining | PubMed |
| Development and Validation of Small-Size Mechanism for RP-3 Aviation Fuel with High Precision. | ACS Omega | 2023 | 37599952 | PubTator, text mining | PubMed |
| Rod and Cone Function Measured Objectively by Chromatic Pupil Campimetry Show a Different Preservation Between Distinct Genotypes in Retinitis Pigmentosa. | Invest Ophthalmol Vis Sci | 2023 | 37578425 | PubTator, text mining | PubMed |
| Defective airway intraflagellar transport underlies a combined motile and primary ciliopathy syndrome caused by IFT74 mutations. | Hum Mol Genet | 2023 | 37555648 | PubTator, text mining | PubMed |
| Recent advances in auxin biosynthesis and homeostasis. | 3 Biotech | 2023 | 37547917 | PubTator, text mining | PubMed |
| What did CRISPR-Cas9 accomplish in its first 10 years? | Biochem Med (Zagreb) | 2023 | 37545694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=11